Laboratory Corporation of America Holdings
- Jurisdiction
United States - ISIN
US5049221055 (LH )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€338.93 43.6% undervalued - Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Read full profile
Fundamentals
- Net revenue
€11.50B - Gross margin
28.1% - EBIT
€1.02B - EBIT margin
8.8% - Net income
€651.14M - Net margin
5.7%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
- Last dividend amount
-
$0.72 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
31.7%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Robert Bresnahan | May 31, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | May 8, 2025 | $1.00K–$15.00K |
| Gilbert Cisneros | April 7, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | March 27, 2025 | $1.00K–$15.00K |
| John James | September 2, 2024 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Ray Dalio |
|
|
|
Sell |
Earnings Calls
Latest earnings call: April 25, 2024 (Q1 2024)